baltimore conference logo
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

The Role of JAK2 Inhibition in Patients With PV

December 4, 2017
John Mascarenhas, MD

John Mascarenhas, MD, associate professor, Icahn School of Medicine at Mount Sinai, discusses the role of <em>JAK2</em> inhibition in patients with polycythemia vera (PV).

John Mascarenhas, MD, associate professor, Icahn School of Medicine at Mount Sinai, discusses the role ofJAK2